BMS-345541 Hydrochloride: Selective IKK Inhibitor for NF-κB Pathway Research

Executive Summary: BMS-345541 hydrochloride is a potent, selective inhibitor of IκB kinase (IKK) isoforms IKK-1 and IKK-2, with IC50 values of 4 μM and 0.3 μM respectively, verified in cellular assays (APExBIO product data). This compound blocks NF-κB-dependent transcription of key pro-inflammatory cytokines, including TNFα and IL-1β, through allosteric binding to IKK (Du et al., 2021). BMS-345541 hydrochloride exhibits high water solubility (≥60 mg/mL) and 100% oral bioavailability in animal models. It induces apoptosis and G2/M phase arrest in T-cell acute lymphoblastic leukemia (T-ALL) cell lines, offering unique translational research opportunities. Its selectivity profile and defined mechanism make it a reference tool for studies on inflammation, apoptosis, and cancer cell signaling.

Biological Rationale

The NF-κB pathway is a central regulator of immune and inflammatory responses. Activation of NF-κB is controlled by the IκB kinase (IKK) complex, which phosphorylates inhibitors of κB (IκB), leading to their degradation and subsequent translocation of NF-κB to the nucleus (Du et al., 2021). Aberrant activation of NF-κB is implicated in chronic inflammation, autoimmune disease, and cancer. IKK consists of two catalytic subunits (IKK-1/IKKα and IKK-2/IKKβ) and a regulatory subunit (NEMO). The pathway's role in modulating pro-inflammatory cytokine production, apoptosis, and cell proliferation makes it a high-value target for research and therapeutic intervention. In particular, T-cell acute lymphoblastic leukemia (T-ALL) and other malignancies exploit NF-κB signaling for survival and chemoresistance (Strategic Targeting of the IKK/NF-κB Pathway), and dissecting this pathway with selective inhibitors such as BMS-345541 hydrochloride is critical for translational science.

Mechanism of Action of BMS-345541 hydrochloride

BMS-345541 hydrochloride is a small-molecule allosteric inhibitor targeting IKK-1 and IKK-2. It binds to a unique, non-ATP competitive site on the IKK catalytic domain. This interaction blocks stimulus-induced phosphorylation and degradation of IκB, preventing nuclear translocation of NF-κB and downstream gene transcription (Du et al., 2021). The compound does not inhibit other serine/threonine or tyrosine kinases at comparable concentrations, confirming its selectivity. In vitro, BMS-345541 hydrochloride suppresses transcription of pro-inflammatory cytokines such as TNFα, IL-1β, IL-6, and IL-8. In vivo, oral administration results in complete inhibition of TNFα production and high systemic exposure (APExBIO). This mechanism makes BMS-345541 hydrochloride a robust tool for selectively modulating the IKK/NF-κB axis in both basic and translational research settings.

Evidence & Benchmarks

• BMS-345541 hydrochloride inhibits IKK-1 and IKK-2 with IC50 values of 4 μM and 0.3 μM, respectively, determined in kinase assays (APExBIO).
• It does not inhibit unrelated serine/threonine or tyrosine kinases at concentrations up to 100 μM, confirming specificity (Strategic Targeting of the IKK/NF-κB Pathway).
• BMS-345541 hydrochloride induces apoptosis and G2/M phase arrest in T-ALL cell lines, with measurable increases in sub-G1 DNA content and caspase activation (Du et al., 2021).
• Oral administration in rodents yields 100% bioavailability and complete inhibition of TNFα production in LPS challenge models (APExBIO).
• Solubility in water is ≥60 mg/mL at room temperature; insoluble in ethanol and DMSO (APExBIO).
• Stock solutions are stable for several months at -20°C, provided they are protected from light and moisture (APExBIO).
• Prevents stimulus-induced phosphorylation of IκB without affecting JNK, ERK, or p38 MAPK signaling pathways (BMS-345541 Hydrochloride: Strategic Disruption).

Applications, Limits & Misconceptions

BMS-345541 hydrochloride is widely used for:

• Dissecting NF-κB pathway activation in models of inflammation, immunity, and oncology.
• Evaluating the role of IKK inhibition in apoptosis and necroptosis, particularly in T-ALL and chemoresistant cancers (Precision IKK Inhibition for Translational Research).
• Screening pro-inflammatory cytokine gene expression under defined inhibitor conditions.
• Validating pathway specificity in cell-based and animal assays due to its lack of off-target kinase effects.

Compared to older analyses emphasizing BMS-345541's unique allosteric mechanism, this article integrates recent findings on RIPK1/NF-κB crosstalk and benchmarks in chemoresistant leukemia. For an in-depth review of workflow optimization and future directions, see this related article, which focuses on integrating IKK inhibition with cell death regulation.

Common Pitfalls or Misconceptions

• BMS-345541 hydrochloride does not inhibit upstream kinases such as TAK1 or unrelated signaling pathways (MAPKs, JAKs) at standard working concentrations.
• It is not suitable for use in ethanol or DMSO-based assays due to poor solubility; only aqueous stock solutions are stable and effective.
• Long-term storage of working solutions at room temperature leads to degradation and reduced potency.
• It should not be used to infer effects on NF-κB-independent cell death mechanisms, as its action is strictly through IKK inhibition.
• In vivo, its effects are limited to models with accessible oral or intravenous administration due to pharmacokinetic properties.

Workflow Integration & Parameters

For optimal use of BMS-345541 hydrochloride (APExBIO A3248), prepare fresh aqueous stock solutions at concentrations up to 60 mg/mL. Store aliquots at -20°C to maintain activity for several months. Use freshly thawed solutions and avoid repeated freeze-thaw cycles. In cell culture, typical working concentrations range from 0.1–10 μM, depending on the desired degree of IKK inhibition and cell type sensitivity. In animal studies, oral dosing achieves rapid and complete systemic exposure. Monitor cytokine production, cell viability, and cell cycle parameters as primary readouts. For pathway specificity, confirm the lack of effect on ERK, JNK, and p38 MAPK phosphorylation as internal controls. Integrate BMS-345541 hydrochloride into multi-parameter experimental designs to dissect NF-κB-dependent transcriptional responses and apoptotic signaling. For comprehensive guidance, consult the BMS-345541 hydrochloride product page and recent methodological reviews.

Conclusion & Outlook

BMS-345541 hydrochloride is a benchmark-selective IKK inhibitor, enabling precise dissection of the NF-κB pathway in models of inflammation, apoptosis, and cancer. Its unmatched selectivity, high oral bioavailability, and robust in vivo performance make it the reagent of choice for studies targeting IKK/NF-κB signaling. As emerging research highlights the interplay between IKK/NF-κB and RIPK1-mediated cell death, BMS-345541 hydrochloride is poised to accelerate discoveries in immunology and oncology (Du et al., 2021). For cutting-edge translational research, APExBIO’s BMS-345541 hydrochloride sets the standard for specificity and reproducibility.